Catalyst Wire Dossier Catalyst Wire Dossier

Inhaled insulin (insulin inhalation powder)

insulin inhalation powder · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Inhaled insulin (insulin inhalation powder), covering 2017-03-01 to 2017-03-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes [Phase 3]

See pricing